Maria De Santis

Medical University of Vienna

Papers

1

Total Citations

52

H-Index

1

About

Maria De Santis is a leading oncologist whose research has fundamentally shaped the management of prostate cancer, particularly through the critical evaluation of focal ablative therapies. Her most cited work, a comprehensive 2021 systematic review, meticulously compares focal therapy against standard management options for clinically localized prostate cancer. By highlighting the limitations of existing evidence, De Santis provides clear, actionable recommendations for both clinical practice and future research, directly addressing a major gap in the field. This landmark paper, with over 50 citations, serves as an essential guide for clinicians navigating the evolving landscape of prostate cancer treatment. De Santis’s contributions extend beyond this review; she is widely recognized for her expertise in integrating novel therapeutic approaches with established protocols, ensuring that patient outcomes remain the central focus. Her rigorous, evidence-based analyses have made her a trusted voice in urologic oncology, influencing how the medical community approaches treatment decisions for localized disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research
52 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: Medical University of Vienna

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago